Poland· PL-100097752

Spasmolina

A alverine product containing alverini citras, registered in Poland by Przedsiębiorstwo Farmaceutyczno-Chemiczne "Synteza" Sp. z o.o.. The same ATC class is registered in 4 of our 19 countries.

ATC A03AX08

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedSpasmolinaATCA03AX08REGISTER NO.PL-100097752PACKS LISTED1CHECKEDSeptember 27, 2026

Where it is registered

Alverine is registered in 4 of 19 countries.

Countries holding a registration under ATC A03AX08 (alverine), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 2 of them publish a price we can compare per daily dose

Alverine · ATC A03AX08

4 / 19 countries

  • Belgiumprice
  • Ireland
  • Polandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Alverini citras
Manufacturer
Przedsiębiorstwo Farmaceutyczno-Chemiczne "Synteza" Sp. z o.o.
Country
Poland (PL)
ATC code
A03AX08
ATC class
Alverine
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05909990456314

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Alverine in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All alverine products

Authorised across Europe · EMA

The same active substance is authorised in 4 EEA countries. Names it is sold under:

  • Belgium · Spasmine, Spasmine Forte
  • United Kingdom (Northern Ireland) · Alverine Citrate, Alverine Citrate Blackrock Pharmaceuticals
  • Ireland · Spasmonal
  • Luxembourg · Spasmine, Spasmine Forte

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/9ed45e6a-bf4f-4a10-bff8-de0fd8582e3c
GET /v1/drugs/9ed45e6a-bf4f-4a10-bff8-de0fd8582e3c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Kapsułki twarde",
  "source": "urpl",
  "strength": "60 mg",
  "packaging": "05909990456314 ¦ Rp ¦ 14749\n20 kaps.",
  "substance": "Alverini citras 60 mg",
  "common_name": "Alverini citras",
  "pl_product_id": "100097752",
  "pozwolenie_nr": "04563",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}

See everything about alverine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.